Atrial Fibrillation (AFib) clinical trials
135 active trials name this condition (recorded in the registry as “Atrial Fibrillation”) . Describe your situation to see which ones look like a fit.
By location
- Prospective Remapping With Concomitant Left Atrial Appendage Occlusion to Ensure Durable Electroporation Study
- A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
- Applause Study I - Append System Early Feasibility Study
- Renal Denervation + PVI vs PVI Alone for Persistent AF
- Chloroquine for Patients With Symptomatic Persistent Atrial Fibrillation: A Prospective Pilot Study
- Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
- TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
- Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
- PVI Alone Versus PVI Plus PWI and SVCI With PFA
- Comparing the Safety and Efficacy of Apixaban and Rivaroxaban
- Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
- Medtronic Terminate AF Study
- Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
- Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
- Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation
- Endocardial Mapping With the CoreMap EP Mapping System
- Optimal Pacing Rate for Cardiac Resynchronization Therapy
- Exercise Activity Intervention With Sensor-Based Engagement in Patients With Atrial Fibrillation
- Sleep Apnea Triggers of Atrial Fibrillation: N-of-1 Randomized Control Trial (SPARTA):
- The Fourth Left Atrial Appendage Occlusion Study
- Ondansetron for the Management of Atrial Fibrillation
- ARIADNE Clinical Trial
- A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
- Prevention of Postoperative Atrial Fibrillation (POAF) Using Intra-Pericardial Amiodarone
- CardioFocus HeartLight Post-Approval Study
- A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
- A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation
- Low Voltage-Directed Catheter Ablation for Atrial Fibrillation
- Esophageal Temperature During PVI Using Q-DOT Micro
- Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR
- PREACTIVE: Preconditioning Exercise Intervention to Improve Symptoms and Quality of Life in Comorbid Atrial Fibrillation and HFpEF
- Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
- Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)
- A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation
- CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
- Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation
- Home Hospital for Suddenly Ill Adults
- The CONFORM Pivotal Trial
- Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- Digitally Rendered Interventions And Knowledge To Limit Ethanol-Associated Atrial Fibrillation Severity
- Amiodarone-Infused CardiaMend Patches for the Prevention of New-Onset POAF in Cardiac Surgery Subjects
- Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot Study
- RiLuzole to Reduce Atrial FIb Study Using Holter Monitoring
- The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
- Anthocyanin-Rich Table Grape Powder for Prophylaxis of Post-Operative Atrial Fibrillation
- Prevention of Postop Atrial Fibrillation Through Intraoperative Inducibility of Atrial Fibrillation and Amiodarone Treatment
- Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Atrial Fibrillation” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.